Status:
COMPLETED
Effect of Lymph Node Ratio in Gastric Cancer to Determine Recurrence Rate After Curative Resection
Lead Sponsor:
Mahidol University
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
D2 gastrectomy is standard treatment of early gastric cancer in Japan but in other countries there is still some discord, especially in Europe and North America. Although the quantity of metastasis ca...
Detailed Description
A retrospective chart review was made of all patients who presented with gastric cancer after curative surgery resection from January 1, 1995 to December 31, 2016 in Ramathibodi Hospital.Data of metas...
Eligibility Criteria
Inclusion
- Gastric cancer after curative surgery resection
- No received neoadjuvant therapy
- Patients have tissues confirmed by Pathology
- Staging used esophagogastroduodenoscopy (EGD) or imaging, including ultrasonography, Computer Tomography (CT) or Magnetic Resonance Imaging (MRI
- Surgery was performed for curative intent and D2 lymphadenectomy and according from Japanese guideline for gastric cancer
Exclusion
- Distant metastasis during surgery
Key Trial Info
Start Date :
December 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2019
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT03778710
Start Date
December 18 2018
End Date
February 20 2019
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chairat Supsamutchai
Bangkok, Bankok, Thailand, 10400